Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Computational Biology Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The computational biology market size has experienced significant expansion over recent years. It is anticipated to expand from $9.47 billion in 2025 to $11.68 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 23.4%. This past growth can be attributed to progress in genomic sequencing technologies, a rise in the availability of biological datasets, increasing partnerships between biology and computer science fields, the expansion of bioinformatics research in academia, and the initial integration of computational modeling in the life sciences.
The computational biology market is anticipated to experience substantial growth in the coming years. It is projected to reach $27.32 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.7%. This expansion during the forecast period is fueled by an increasing demand for precision medicine solutions, rising investments in drug discovery analytics, the widespread development of cloud-based bioinformatics platforms, the expanding application of AI-driven biological insights, and a growing dependence on data-driven clinical research. Significant trends during this time include the rising use of algorithm-driven biological modeling, increased adoption of in-silico drug discovery tools, the broadening integration of multi-omics data analysis, the expansion of high-performance computing in biological applications, and a reinforced focus on predictive biological simulations.
Download A Free Sample Report For Comprehensive Market Insights:
Computational Biology Market Demand Drivers: What Is Fueling Industry Growth?
The future expansion of computational biology is anticipated to be driven by the rising need for personalized medicine. This approach, also termed precision medicine, focuses on medical treatment and healthcare services by considering individual differences in genetic makeup, environmental factors, and lifestyle when creating patient treatment strategies. Personalized medicine depends on the analysis of an individual’s genetic data to customize medical interventions. Computational biology is crucial for deciphering this genetic information, facilitating the creation of targeted therapies, refining treatment protocols, and forecasting treatment efficacy. Furthermore, it aids in categorizing patients into distinct subgroups, lowering healthcare expenditures, and adhering to both regulatory and clinical standards. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Consequently, the growing demand for personalized medicine is propelling the growth of the computational biology market.
Computational Biology Market Segment Performance And Strategic Opportunities
The computational biology market covered in this report is segmented –
1) By Services: In-house, Contract
2) By Tools: Databases, Infrastructure (Hardware), Analysis Software and Services
3) By Application: Cellular and Biological Simulation, Drug Discovery and Disease Modelling
4) By End User: Research, Pharmaceutical Industry, Commercial Applications
Subsegments:
1) By In-house: Data Analysis, Software Development, Research And Development
2) By Contract: Outsourced Bioinformatics, Collaborative Research, Data Management Services
#Computational Biology Market Growth Trends: What Is Influencing The Future Outlook?
Leading firms within the computational biology sector are creating novel solutions for proteomics investigation, aiming to secure a market advantage. This discipline, proteomics research, involves the thorough examination of proteins within a biological framework. An illustration of this trend is Biognosys AG, a Swiss biotechnology firm, which introduced Spectronaut 18 in May 2023, revealing substantial scientific and technological improvements for its specialized proteomics research software and product line. Spectronaut 18 provides elevated throughput and enhanced efficiency for data-independent acquisition (DIA) proteomics analysis. Furthermore, the company’s TrueDiscovery platform facilitates faster biomarker identification in areas such as oncology and neuroscience by delivering exceptional depth and sensitivity in proteomics. TrueTarget supports precise drug target identification and deconvolution, while Biognosys’ iRT Kit, advised for continuous system suitability checks, now integrates with Bruker ProteoScape software.
Computational Biology Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the computational biology market are Certara L.P.; Chemical Computing Group Inc.; Compugen Ltd.; Genedata AG; Dassault Systèmes SE; Rosa & Co. LLC; Simulation Plus Inc.; Nimbus Discovery LLC; Rhenovia Pharma SAS; DNAnexus; Genialis Inc.; BC Platforms; Schrodinger Inc.; Strand Life Sciences; Numerate Inc.; Insitro; Recursion Pharmaceuticals; Atomwise; Relay Therapeutics; Exscientia
Access The Complete Computational Biology Market Report:
Computational Biology Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the computational biology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computational biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
